title: Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates.
authors: J Michael
authors: JM
authors: Soucie
authors: Paul E
authors: PE
authors: Monahan
authors: Roshni
authors: R
authors: Kulkarni
authors: Christine
authors: C
authors: De Staercke
authors: Michael
authors: M
authors: Recht
authors: Meera B
authors: MB
authors: Chitlur
authors: Ralph
authors: R
authors: Gruppo
authors: W Craig
authors: WC
authors: Hooper
authors: Craig
authors: C
authors: Kessler
authors: Marilyn J
authors: MJ
authors: Manco-Johnson
authors: Jerry
authors: J
authors: Powell
authors: Meredith
authors: M
authors: Pyle
authors: Brenda
authors: B
authors: Riske
authors: Hernan
authors: H
authors: Sabio
authors: Sean
authors: S
authors: Trimble
mesh_terms: D001779:Blood Coagulation Factors / Q000009:adverse effects*; D005260:Female; D006467:Hemophilia A; D006801:Humans; D008297:Male; D010322:Parvoviridae Infections / Q000097:blood* / Q000635:transmission*; D016732:Parvovirus B19, Human / Q000302:isolation & purification*
chemical_list: D001779:Blood Coagulation Factors